These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37672543)

  • 21. Abrogated cryptic activation of lentiviral transfer vectors.
    Luche RM; Enssle J; Kiem HP
    Sci Rep; 2012; 2():438. PubMed ID: 22666541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helper plasmids for production of HIV-1-derived vectors.
    Fuller M; Anson DS
    Hum Gene Ther; 2001 Nov; 12(17):2081-93. PubMed ID: 11747598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient and Highly Specific Gene Transfer Using Mutated Lentiviral Vectors Redirected with Bispecific Antibodies.
    Parker CL; Jacobs TM; Huckaby JT; Harit D; Lai SK
    mBio; 2020 Jan; 11(1):. PubMed ID: 31964730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Gene Therapy: Development and Production of Lentiviral Vectors for Gene Therapy.
    Coroadinha AS
    Methods Mol Biol; 2022; 2521():297-315. PubMed ID: 35733005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and construction of a recombinant lentiviral vector with specific tropism to human epidermal growth factor-overexpressed cancer cells: Developing a new retargeting system for lentivirus vectors.
    Ebrahimabadi S; Shahbazi M; Akbari M; Golalipour M; Farazmandfar T
    J Gene Med; 2019 Jun; 21(6):e3095. PubMed ID: 31050357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multigene lentiviral vector system based on differential splicing.
    Zhu Y; Planelles V
    Methods Mol Med; 2003; 76():433-48. PubMed ID: 12526178
    [No Abstract]   [Full Text] [Related]  

  • 27. [Inhibition of HIV-1 in vitro by combination of vpr and tat specific short hairpin RNA via lentiviral vectors].
    Hao YZ; Teng ZP; Yang YS; Sun XN; Ma J; Jin XH; Zeng Y
    Bing Du Xue Bao; 2013 Mar; 29(2):126-31. PubMed ID: 23757841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
    Macías D; Oya R; Saniger L; Martín F; Luque F
    Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimized Lentiviral Transduction Protocols by Use of a Poloxamer Enhancer, Spinoculation, and scFv-Antibody Fusions to VSV-G.
    Anastasov N; Höfig I; Mall S; Krackhardt AM; Thirion C
    Methods Mol Biol; 2016; 1448():49-61. PubMed ID: 27317172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of a trans protease lentiviral packaging system that produces high titer virus.
    Westerman KA; Ao Z; Cohen EA; Leboulch P
    Retrovirology; 2007 Dec; 4():96. PubMed ID: 18163907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of stable packaging cell lines for clinical lentiviral vector production.
    Sanber KS; Knight SB; Stephen SL; Bailey R; Escors D; Minshull J; Santilli G; Thrasher AJ; Collins MK; Takeuchi Y
    Sci Rep; 2015 Mar; 5():9021. PubMed ID: 25762005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved third-generation lentiviral packaging with pLKO.1C vectors.
    Lee S; Cobrinik D
    Biotechniques; 2020 Jun; 68(6):349-352. PubMed ID: 32141762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Engineered MARCH8-Resistant Vesicular Stomatitis Virus Glycoprotein Enhances Lentiviral Vector Transduction.
    Xu F; Liu X; Zhang D; Zhao F; Fan Z; Hu S; Mei S; Huang Y; Sun H; Wei L; Guo L; Wang J; Cen S; Liang C; Guo F
    Hum Gene Ther; 2021 Sep; 32(17-18):936-948. PubMed ID: 33678011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lentiviral vectors: optimization of packaging, transduction and gene expression.
    Delenda C
    J Gene Med; 2004 Feb; 6 Suppl 1():S125-38. PubMed ID: 14978756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
    Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
    Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mass spectrometry analysis reveals differences in the host cell protein species found in pseudotyped lentiviral vectors.
    Johnson S; Wheeler JX; Thorpe R; Collins M; Takeuchi Y; Zhao Y
    Biologicals; 2018 Mar; 52():59-66. PubMed ID: 29361371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-Globin Lentiviral Vectors Have Reduced Titers due to Incomplete Vector RNA Genomes and Lowered Virion Production.
    Han J; Tam K; Ma F; Tam C; Aleshe B; Wang X; Quintos JP; Morselli M; Pellegrini M; Hollis RP; Kohn DB
    Stem Cell Reports; 2021 Jan; 16(1):198-211. PubMed ID: 33186538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.
    Olgun HB; Tasyurek HM; Sanlioglu AD; Sanlioglu S
    Methods Mol Biol; 2019; 1879():323-345. PubMed ID: 29797007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of Lentiviral Vectors for Targeted Integration and Protein Delivery.
    Schenkwein D; Ylä-Herttuala S
    Methods Mol Biol; 2016; 1448():185-98. PubMed ID: 27317182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1.
    Kim VN; Mitrophanous K; Kingsman SM; Kingsman AJ
    J Virol; 1998 Jan; 72(1):811-6. PubMed ID: 9420292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.